Contract with Customer, Liability, Current of Allogene Therapeutics, Inc. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: Allogene Therapeutics, Inc. quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2019 to 31 Mar 2024.
Allogene Therapeutics, Inc. Contract with Customer, Liability, Current for the quarter ending 31 Mar 2024 was $86,000, unchanged year-over-year.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Current, Quarterly (USD)

Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Allogene Therapeutics, Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$86,000	$0	0%	31 Mar 2024	10-Q	13 May 2024	2024	Q1
Q4 2023	$86,000	-$9,000	-9.5%	31 Dec 2023	10-Q	13 May 2024	2024	Q1
Q3 2023	$86,000	-$13,000	-13%	30 Sep 2023	10-K	14 Mar 2024	2023	FY
Q2 2023	$86,000	-$18,000	-17%	30 Jun 2023	10-K	14 Mar 2024	2023	FY
Q1 2023	$86,000	-$61,000	-41%	31 Mar 2023	10-K	14 Mar 2024	2023	FY
Q4 2022	$95,000	-$61,000	-39%	31 Dec 2022	10-K	14 Mar 2024	2023	FY
Q3 2022	$99,000	-$266,000	-73%	30 Sep 2022	10-K	14 Mar 2024	2023	FY
Q2 2022	$104,000	-$201,000	-66%	30 Jun 2022	10-K	14 Mar 2024	2023	FY
Q1 2022	$147,000	-$92,000	-38%	31 Mar 2022	10-K	14 Mar 2024	2023	FY
Q4 2021	$156,000	-$38,836,000	-100%	31 Dec 2021	10-K/A	14 Mar 2024	2022	FY
Q3 2021	$365,000			30 Sep 2021	10-Q	04 Nov 2021	2021	Q3
Q2 2021	$305,000			30 Jun 2021	10-Q	04 Aug 2021	2021	Q2
Q1 2021	$239,000			31 Mar 2021	10-Q	05 May 2021	2021	Q1
Q4 2020	$38,992,000	+$38,992,000		31 Dec 2020	10-K	23 Feb 2022	2021	FY
Q4 2019	$0			31 Dec 2019	10-K	25 Feb 2021	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.